Cargando…

Systematic evaluation of the efficacy–effectiveness gap of systemic treatments in metastatic nonsmall cell lung cancer

The divergence between clinical trial results and real-world outcomes is largely unknown for many cancer types. The present study aims overall to assess the efficacy–effectiveness gap (difference between outcomes in clinical trials and the real world) in systemic treatment for metastatic nonsmall ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cramer-van der Welle, Christine M., Peters, Bas J.M., Schramel, Franz M.N.H., Klungel, Olaf H., Groen, Harry J.M., van de Garde, Ewoudt M.W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306150/ https://www.ncbi.nlm.nih.gov/pubmed/30487206 http://dx.doi.org/10.1183/13993003.01100-2018

Ejemplares similares

Real-world outcomes versus clinical trial results of immunotherapy in stage IV non-small cell lung cancer (NSCLC) in the Netherlands
por: Cramer-van der Welle, Christine M., et al.
Publicado: (2021)

Trends in Drug Costs and Overall Survival in Patients with Metastatic Non-small Cell Lung Cancer in The Netherlands Diagnosed from 2008 Through 2014
por: Cramer-van der Welle, Christine M., et al.
Publicado: (2020)

Real‐world treatment patterns and outcomes of patients with extensive disease small cell lung cancer
por: Cramer‐van der Welle, Christine M., et al.
Publicado: (2020)

‘Care for Outcomes’: systematic development of a set of outcome indicators to improve patient-relevant outcomes for patients with lung cancer
por: Cramer-van der Welle, Christine M, et al.
Publicado: (2021)

Development and validation of a decision model for the evaluation of novel lung cancer treatments in the Netherlands
por: Mfumbilwa, Zakile A., et al.
Publicado: (2023)

The association between gut microbiome affecting concomitant medication and the effectiveness of immunotherapy in patients with stage IV NSCLC
por: Verschueren, M. V., et al.
Publicado: (2021)

Treatment patterns and clinical outcomes of chemotherapy treatment in patients with muscle-invasive or metastatic bladder cancer in the Netherlands
por: Reesink, Daan J., et al.
Publicado: (2020)

Real-World Effectiveness of Palbociclib Versus Clinical Trial Results in Patients With Advanced/Metastatic Breast Cancer That Progressed on Previous Endocrine Therapy
por: Bui, Tam Binh V, et al.
Publicado: (2019)

GMP-compliant (68)Ga radiolabelling in a conventional small-scale radiopharmacy: a feasible approach for routine clinical use
por: Vis, Roeland, et al.
Publicado: (2015)

The effects of pharmacological interventions on quality of life and fatigue in sarcoidosis: a systematic review
por: Vis, Roeland, et al.
Publicado: (2020)

Development of the First Patient-centred Set of Outcomes for Muscle-invasive and Metastatic Bladder Cancer: A Multicentre Initiative
por: Reesink, Daan J., et al.
Publicado: (2021)

Pharmacogenomic insights into treatment and management of statin-induced myopathy
por: Peters, Bas JM, et al.
Publicado: (2009)

The Influence of Long-Acting Somatostatin Analogs on (68)Ga-DOTATATE Uptake in Patients With Neuroendocrine Tumors
por: Chahid, Youssef, et al.
Publicado: (2023)

Website Visitors Asking Questions Online to Lung Cancer Specialists: What Do They Want To Know?
por: Schook, Romane M, et al.
Publicado: (2013)

Needs with Regard to Decision Support Systems for Treating Patients with Incurable Non-small Cell Lung Cancer
por: Révész, Dóra, et al.
Publicado: (2019)

Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from first-line immunotherapy in NSCLC
por: Ismail, R. K., et al.
Publicado: (2023)

Correction: Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from second-line immunotherapy in NSCLC
por: Ismail, R. K., et al.
Publicado: (2023)

Randomised controlled trial of first-line tyrosine-kinase inhibitor (TKI) versus intercalated TKI with chemotherapy for EGFR-mutated nonsmall cell lung cancer
por: Gijtenbeek, Rolof G.P., et al.
Publicado: (2022)

Modelling approach to simulate reductions in LDL cholesterol levels after combined intake of statins and phytosterols/-stanols in humans
por: Eussen, Simone RBM, et al.
Publicado: (2011)

An All-In-One Transcriptome-Based Assay to Identify Therapy-Guiding Genomic Aberrations in Nonsmall Cell Lung Cancer Patients
por: Wei, Jiacong, et al.
Publicado: (2020)

Estimating quality adjusted progression free survival of first-line treatments for EGFR mutation positive non small cell lung cancer patients in The Netherlands
por: Verduyn, S Cora, et al.
Publicado: (2012)

Why Do Patients and Caregivers Seek Answers From the Internet and Online Lung Specialists? A Qualitative Study
por: Schook, Romane Milia, et al.
Publicado: (2014)

Rapidity Gaps Between Jets
por: Butterworth, J.M., et al.
Publicado: (1996)

CYP3A4 inhibitors do not influence [(68)Ga]Ga-DOTA-TATE uptake in liver tissue
por: Chahid, Youssef, et al.
Publicado: (2023)

Antibiotic prescribing on admission to patients with pneumonia and prior outpatient antibiotic treatment: a cohort study on clinical outcome
por: van de Garde, Ewoudt M W, et al.
Publicado: (2015)

Risk factors for nonvisualization of the sentinel lymph node on lymphoscintigraphy in breast cancer patients
por: Chahid, Youssef, et al.
Publicado: (2021)

Cost-effectiveness of screening smokers and ex-smokers for lung cancer in the Netherlands in different age groups
por: Al Khayat, Mohamed N. M. T., et al.
Publicado: (2022)

A systematic literature review on the efficacy–effectiveness gap: comparison of randomized controlled trials and observational studies of glucose-lowering drugs
por: Ankarfeldt, Mikkel Z, et al.
Publicado: (2017)

Latent class analysis-based subgroups and response to corticosteroids in hospitalised community-acquired pneumonia patients: a validation study
por: Wittermans, Esther, et al.
Publicado: (2023)

Adaptive intrapatient dose escalation of cisplatin in combination with low-dose vp16 in patients with nonsmall cell lung cancer
por: Schellens, J H M, et al.
Publicado: (2003)

Prior outpatient antibiotic use as predictor for microbial aetiology of community-acquired pneumonia: hospital-based study
por: van de Garde, Ewoudt MW, et al.
Publicado: (2007)

The dynamics in applied COVID-19 pharmacotherapy and the influence of national guidance in The Netherlands: a quantitative and qualitative study
por: Uitvlugt, Elien B, et al.
Publicado: (2022)

Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis
por: Spoorenberg, Simone MC, et al.
Publicado: (2014)

Statins and prevention of infections: systematic review and meta-analysis of data from large randomised placebo controlled trials
por: van den Hoek, Hester L, et al.
Publicado: (2011)

Efficacy of Ibandronate Loading Dose on Rapid Pain Relief in Patients With Non-Small Cell Lung Cancer and Cancer Induced Bone Pain: The NVALT-9 Trial
por: Brouns, Anita J. W. M., et al.
Publicado: (2020)

Prognostic Value of Fluoro-D-glucose Uptake of Primary Tumor and Metastatic Lesions in Advanced Nonsmall Cell Lung Cancer
por: Nguyen, Xuan Canh, et al.
Publicado: (2014)

Non-dispersive sensing scheme based on mid-infrared LED and differential mode excitation photoacoustic spectroscopy
por: Rey, J.M., et al.
Publicado: (2023)

Bronchoscopic treatment of inoperable nonsmall cell lung cancer
por: Kniese, Christopher M., et al.
Publicado: (2020)

The Effect of Eighteen-Month Metformin Treatment in Obese Adolescents: Comparison of Results Obtained in Daily Practice with Results from a Clinical Trial
por: van der Aa, Marloes P., et al.
Publicado: (2016)

Practical recommendations to combine small-molecule inhibitors and direct oral anticoagulants in patients with nonsmall cell lung cancer
por: Otten, Leila S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_agu5kdqgdnj8elqufd5ffdr58f